Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Prognostic impact of family history in southern Chinese patients with undifferentiated nasopharyngeal carcinoma.

Ouyang PY, Su Z, Mao YP, Liang XX, Liu Q, Xie FY.

Br J Cancer. 2013 Aug 6;109(3):788-94. doi: 10.1038/bjc.2013.343. Epub 2013 Jun 27.

2.
3.

Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.

Liu X, Li X, Jiang N, Lei Y, Tang LL, Chen L, Zhou GQ, Sun Y, Yue D, Guo R, Mao YP, Li WF, Liu LZ, Tian L, Lin AH, Ma J.

Cancer. 2014 Jan 1;120(1):68-76. doi: 10.1002/cncr.28377. Epub 2013 Sep 24.

4.

Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.

Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ.

J Natl Cancer Inst. 2011 Dec 7;103(23):1761-70. doi: 10.1093/jnci/djr432. Epub 2011 Nov 4.

PMID:
22056739
5.

Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.

Liang SB, Deng YM, Zhang N, Lu RL, Zhao H, Chen HY, Li SE, Liu DS, Chen Y.

BMC Cancer. 2013 May 27;13:260. doi: 10.1186/1471-2407-13-260.

7.

Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.

Chen YP, Tang LL, Zhang WN, Mao YP, Chen L, Sun Y, Liu LZ, Li WF, Liu X, Zhou GQ, Guo R, Mai HQ, Shao JY, Lin AH, Li L, Ma J.

Medicine (Baltimore). 2015 Oct;94(43):e1624. doi: 10.1097/MD.0000000000001624.

8.

Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.

Ozyar E, Gurkaynak M, Yildiz F, Atahan IL.

Radiother Oncol. 2004 Jul;72(1):71-7.

PMID:
15236877
9.

Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer.

Zhang W, Chen Y, Zhou G, Liu X, Chen L, Tang L, Mao Y, Sun Y, Ma J.

Medicine (Baltimore). 2015 Sep;94(37):e1505. doi: 10.1097/MD.0000000000001505.

10.

[Influence of level-Ib lymphadenopathy on the prognosis of nasopharyngeal carcinoma].

Yi W, Liu XM, Xia YF, Liu Q, Li JT.

Chin J Cancer. 2010 Jan;29(1):87-93. Chinese.

11.

Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.

Su SF, Han F, Zhao C, Huang Y, Chen CY, Xiao WW, Li JX, Lu TX.

Chin J Cancer. 2011 Aug;30(8):565-73. doi: 10.5732/cjc.010.10547.

12.

[Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system].

Mao YP, Hong MH, Sun Y, Liang SB, Li L, Liu LZ, Tang LL, Cao SM, Lin AH, Lu TX, Liu MZ, Ma J.

Ai Zheng. 2007 Oct;26(10):1099-106. Chinese.

PMID:
17927881
13.

Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study.

Zhang N, Liang SB, Deng YM, Lu RL, Chen HY, Zhao H, Lv ZQ, Liang SQ, Yang L, Liu DS, Chen Y.

BMC Cancer. 2014 Feb 27;14:136. doi: 10.1186/1471-2407-14-136.

14.

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.

Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ.

J Natl Cancer Inst. 2002 Nov 6;94(21):1614-9.

PMID:
12419787
15.

Prognostic value of ABO blood group in southern Chinese patients with established nasopharyngeal carcinoma.

Ouyang PY, Su Z, Mao YP, Liu Q, Xie FY.

Br J Cancer. 2013 Oct 29;109(9):2462-6. doi: 10.1038/bjc.2013.559. Epub 2013 Sep 10.

16.

Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.

Xiang Y, Yao H, Wang S, Hong M, He J, Cao S, Min H, Song E, Guo X.

Laryngoscope. 2006 Jan;116(1):126-30.

PMID:
16481824
17.

Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.

Zhou GQ, Mao YP, Chen L, Li WF, Liu LZ, Sun Y, Chen Y, Tian L, Lin AH, Li L, Ma J.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1090-7. doi: 10.1016/j.ijrobp.2010.11.063. Epub 2011 Aug 22.

PMID:
21864993
18.

Prognostic impact of cigarette smoking on the survival of patients with established nasopharyngeal carcinoma.

Ouyang PY, Su Z, Mao YP, Liang XX, Liu Q, Deng W, Xie FY.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2285-94. doi: 10.1158/1055-9965.EPI-13-0546. Epub 2013 Nov 19.

19.

Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma.

Fang FM, Tsai WL, Chien CY, Chen HC, Hsu HC, Huang TL, Lee TF, Huang HY, Lee CH.

J Clin Oncol. 2010 Oct 1;28(28):4384-9. doi: 10.1200/JCO.2010.28.8324. Epub 2010 Aug 16.

PMID:
20713853
20.

Nasopharyngeal cancer: impact of skull base invasion on patients prognosis and its potential implications on TNM staging.

Li YZ, Cai PQ, Xie CM, Huang ZL, Zhang GY, Wu YP, Liu LZ, Lu CY, Zhong R, Wu PH.

Eur J Radiol. 2013 Mar;82(3):e107-11. doi: 10.1016/j.ejrad.2012.10.016. Epub 2012 Nov 20.

PMID:
23181975

Supplemental Content

Support Center